Pathology
 |
|
18 february 2020 19:00:05 |
| Long-term outcomes of ruxolitinib therapy in steroid-refractory graft-versus-host disease in children and adults (Bone Marrow Transplantation) |
|
Tweet |
| 169 viewsCategory: Medicine, Pathology |
 A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation (Bone Marrow Transplantation)Plasmapheresis to eliminate immunosuppressive alemtuzumab levels in a child with disseminated adenovirus infection after allogeneic stem cell transplantation (Bone Marrow Transplantation) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
